Завершено
Фаза II
Россия
Placebo; VX-509; VX-509; VX-509; VX-509 · Vertex Pharmaceuticals Incorporated
A 12-week, Double-blind, Randomized, Parallel-group, Placebo-controlled Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid Arthritis